Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 20;9(6):00646-2023.
doi: 10.1183/23120541.00646-2023. eCollection 2023 Nov.

Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on

Affiliations
Editorial

Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on

Effrosyni D Manali et al. ERJ Open Res. .

Abstract

A new study reports the first evidence to "move on" with lung transplantation in adult surfactant-related fibrotic ILDs. It highlights the need for better genetic characterisation of transplant candidates and cancer screening for these patients. https://bit.ly/3QxG73Z.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: E.D. Manali reports grants or contracts from Savara as an IMPALA 2 Trial subinvestigator, outside the submitted work; payment or honoraria for lectures, presentations, speakers’ bureaus or educational events from Boehringer Ingelheim, CSL Behring, Hoffman la Roche and Elpen, outside the submitted work; and support for attending meetings and/or travel from Boehringer Ingelheim, outside the submitted work. Conflict of interest: M. Griese reports consulting fees and support for an adjudication board from Boehringer Ingelheim, outside the submitted work. Conflict of interest: S.A. Papiris reports grants or contracts from Savara as an IMPALA 2 Trial primary investigator, outside the submitted work; payment or honoraria for lectures, presentations, speakers’ bureaus or educational events from Boehringer Ingelheim, CSL Behring, Hoffman la Roche and Elpen, outside the submitted work; and support for attending meetings and/or travel from Boehringer Ingelheim, outside the submitted work.

References

    1. Papiris SA, Kannengiesser C, Borie R, et al. . Genetics in idiopathic pulmonary fibrosis: a clinical perspective. Diagnostics 2022; 12: 2928. doi:10.3390/diagnostics12122928 - DOI - PMC - PubMed
    1. van Moorsel CHM, van der Vis JJ, Grutters JC. Genetic disorders of the surfactant system: focus on adult disease. Eur Respir Rev 2021; 30: 200085. doi:10.1183/16000617.0085-2020 - DOI - PMC - PubMed
    1. Desroziers T, Prévot G, Coulomb A, et al. . Hypomorphic pathogenic variant in SFTPB leads to adult pulmonary fibrosis. Eur J Hum Genet 2023; 31: 1083–1087. doi:10.1038/s41431-023-01413-w - DOI - PMC - PubMed
    1. van Moorsel CHM, Ten Klooster L, van Oosterhout MFM, et al. . SFTPA2 mutations in familial and sporadic idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2015; 192: 1249–1252. doi:10.1164/rccm.201504-0675LE - DOI - PubMed
    1. Nathan N, Giraud V, Picard C, et al. . Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer. Hum Mol Genet 2016; 25: 1457–1467. doi:10.1093/hmg/ddw014 - DOI - PubMed

Publication types

LinkOut - more resources